A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin
In the second part of this clinical trial, researchers led by Sanyal will follow nearly 1,200 participants from 37 countries for up to five years to gather data on semaglutides impact on long-term liver complications
Duracin del tratamiento con GLP-1: es necesario tomarlo siempre
Is there new market opportunities, rather than simply profit loss, the food sector can take advantage of
The incretin effect is significantly blunted in type 2 diabetes mellitus (T2DM) and restoration of this incretin signalling could be effective as a treatment strategy for diabetes, obesity and metabolic dysfunctions [5, 6]
Vitamin B12 injections are commonly used to correct deficiencies and support overall health